People: Johnson & Johnson (JNJ)
27 Mar 2017
Ms. Sandra E. Peterson is Executive Vice President - Group Worldwide Chairman of Johnson & Johnson. Ms. Peterson oversees the Consumer and Consumer Medical Device businesses; the Company's operating infrastructure — Supply Chain, Information Technology, Global Services; Health & Wellness; Global Design; and Health Technology. Prior to joining the Company, Ms. Peterson was Chairman and Chief Executive Officer of Bayer CropScience AG in Germany, previously serving as President and Chief Executive Officer of Bayer Medical Care and President of Bayer HealthCare AG's Diabetes Care Division. Before joining Bayer in 2005, Ms. Peterson held a number of leadership roles at Medco Health Solutions (previously known as Merck-Medco). In April 2016. Ms. Peterson was named Executive Vice President, Group Worldwide Chairman of Johnson & Johnson. Effective June 1, 2017, Ms. Peterson will assume leadership of the Hospital Medical Device business, in addition to her current responsibilities.
|Total Annual Compensation, USD||2,033,650|
|Restricted Stock Awards, USD||3,504,180|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||2,088,620|
|Fiscal Year Total, USD||7,626,450|